_version_ 1783604816857006080
author Sharma, Ashish
Kumar, Nilesh
Parachuri, Nikulaa
Sharma, Rohini
Bandello, Francesco
Kuppermann, Baruch D.
Loewenstein, Anat
author_facet Sharma, Ashish
Kumar, Nilesh
Parachuri, Nikulaa
Sharma, Rohini
Bandello, Francesco
Kuppermann, Baruch D.
Loewenstein, Anat
author_sort Sharma, Ashish
collection PubMed
description
format Online
Article
Text
id pubmed-7608337
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76083372020-11-05 Brolucizumab and immunogenicity Sharma, Ashish Kumar, Nilesh Parachuri, Nikulaa Sharma, Rohini Bandello, Francesco Kuppermann, Baruch D. Loewenstein, Anat Eye (Lond) Comment Nature Publishing Group UK 2020-04-06 2020-10 /pmc/articles/PMC7608337/ /pubmed/32251366 http://dx.doi.org/10.1038/s41433-020-0853-9 Text en © The Royal College of Ophthalmologists 2020
spellingShingle Comment
Sharma, Ashish
Kumar, Nilesh
Parachuri, Nikulaa
Sharma, Rohini
Bandello, Francesco
Kuppermann, Baruch D.
Loewenstein, Anat
Brolucizumab and immunogenicity
title Brolucizumab and immunogenicity
title_full Brolucizumab and immunogenicity
title_fullStr Brolucizumab and immunogenicity
title_full_unstemmed Brolucizumab and immunogenicity
title_short Brolucizumab and immunogenicity
title_sort brolucizumab and immunogenicity
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608337/
https://www.ncbi.nlm.nih.gov/pubmed/32251366
http://dx.doi.org/10.1038/s41433-020-0853-9
work_keys_str_mv AT sharmaashish brolucizumabandimmunogenicity
AT kumarnilesh brolucizumabandimmunogenicity
AT parachurinikulaa brolucizumabandimmunogenicity
AT sharmarohini brolucizumabandimmunogenicity
AT bandellofrancesco brolucizumabandimmunogenicity
AT kuppermannbaruchd brolucizumabandimmunogenicity
AT loewensteinanat brolucizumabandimmunogenicity